SCHEMBL7013293

SCHEMBL7013293

Nc1ccc(Oc2ccc3nc[nH]c3c2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.66
MAPT P10636 5/20 0.64
KDM4E B2RXH2 3/20 0.64
RAD52 P43351 1/20 0.64
MMP12 P39900 1/20 0.60
ALDH1A1 P00352 6/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MITF O75030 1/20 0.47
GAA P10253 1/20 0.47
GFER P55789 1/20 0.47
NLRP1 Q9C000 1/20 0.47
NOD2 Q9HC29 1/20 0.47
TDP1 Q9NUW8 2/20 0.47
CYP3A4 P08684 2/20 0.47
TSHR P16473 1/20 0.47
APEX1 P27695 1/20 0.46
RECQL P46063 1/20 0.46
BLM P54132 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7013286 0.87 PRKCI (0.51) PRKCIMAPTKDM4ERAD52MMP12
SCHEMBL29770425 0.85 MMP12 (0.62) PRKCIMAPTKDM4ERAD52MMP12
SCHEMBL1799380 0.85 MMP12 (0.62) PRKCIMAPTKDM4ERAD52MMP12
SCHEMBL23636200 0.83 MMP12 (0.60) PRKCIMAPTKDM4ERAD52MMP12
SCHEMBL30467970 0.83 MMP12 (0.60) PRKCIMAPTKDM4ERAD52MMP12
SCHEMBL23636201 0.83 MMP12 (0.60) PRKCIMAPTKDM4ERAD52MMP12
SCHEMBL30468011 0.83 MMP12 (0.60) PRKCIMAPTKDM4ERAD52MMP12
SCHEMBL14547884 0.83 MMP12 (0.55) PRKCIMAPTKDM4ERAD52MMP12
SCHEMBL115966 0.80 PRKCI (1.00) PRKCIMAPTKDM4ERAD52MMP12
SCHEMBL12633810 0.80 P2RY14 (0.58) PRKCIMAPTKDM4ERAD52MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed